{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/150151420"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "attractive terms, we could be forced to significantly delay, scale back or discontinue the development or commercialization of eravacycline or other product candidates, seek collaborators at an earlier stage than otherwise would be desirable or on" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "sec.gov" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/277557970"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/150151420"] } } }
